Recruiting OBSERVATIONAL NCT07277361
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment (FABRY65)
Sponsor: Centre Hospitalier Bretagne Atlantique
Conditions
Aged 65 Years or Older Alpha Galactosidase A Deficiency Fabry Disease Galactosidase A Gene Mutation
Updated 1 time since 2026 Last updated: Dec 9, 2025 Started: Oct 8, 2024 Primary completion: Oct 14, 2029 Completion: Oct 14, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Aged 65 Years or Older and Alpha Galactosidase A Deficiency and is currently actively recruiting participants. Centre Hospitalier Bretagne Atlantique leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Centre Hospitalier Bretagne Atlantique
- Centre Hospitalier Universitaire Dijon
- Centre Hospitalier Universitaire de Caen
- Centre Hospitalier Universitaire de Nice
- Centre Hospitalier de la côte Basque
- Hospices Civils de Lyon
- Hospital, Vannes
- Hôpital Raymond Poincaré
- Nantes University Hospital
- Necker Hospital, 75015 Paris
- Rennes University Hospital
- University Hospital, Angers
- University Hospital, Bordeaux
- University Hospital, Brest
- University Hospital, Clermont-Ferrand
- University Hospital, Grenoble
- University Hospital, Lille
- University Hospital, Limoges
- University Hospital, Marseille
- University Hospital, Montpellier
- University Hospital, Rouen
- University Hospital, Strasbourg
- University Hospital, Tours
- Wladimir MAUHIN, Dr
Data source: Groupe Hospitalier Diaconesses Croix Saint-Simon
For direct contact, visit the study record on ClinicalTrials.gov .